Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (241-250 of 374) with videos related to

Pageof 38
Sort By:
Nature Reviews. Rheumatology|August 11, 2017
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)Nicola Dalbeth, Thomas Bardin, Michael Doherty, et al.
Arthritis and Rheumatism|October 31, 2009
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trialKenneth G Saag, Jose R Zanchetta, Jean-Pierre Devogelaer, et al.
Journal of Evaluation in Clinical Practice|September 15, 2011
Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health planYihua Xu, Hema N Viswanathan, Melea A Ward, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority studyKenneth G Saag, Rachel B Wagman, Piet Geusens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 14, 2012
Recent trends in hip fracture rates by race/ethnicity among older US adultsNicole C Wright, Kenneth G Saag, Jeffrey R Curtis, et al.
Clinical Trials (London, England)|December 19, 2013
Use of health plan combined with registry data to predict clinical trial recruitmentJeffrey R Curtis, Nicole C Wright, Fenglong Xie, et al.
Journal of the American Academy of Dermatology|June 20, 2020
Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosisKenneth G Saag, Tobias J de Villiers, Peter Alexandersen, et al.
Medical Care|March 14, 2017
Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled TrialPeter Cram, Kenneth G Saag, Yiyue Lou, et al.
Archives of Osteoporosis|January 8, 2018
Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) studyDouglas W Roblin, Peter Cram, Yiyue Lou, et al.
The Journal of Rheumatology|January 14, 2004
Nonsteroidal antiinflammatory drug toxicity monitoring and safety practicesFausto G Patino, Jason Olivieri, Jeroan J Allison, et al.
Pageof 38

Showing results (241-250 of 374) with videos related to

Sort By:
Pageof 38
Nature Reviews. Rheumatology|August 11, 2017
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)Nicola Dalbeth, Thomas Bardin, Michael Doherty, et al.
Arthritis and Rheumatism|October 31, 2009
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trialKenneth G Saag, Jose R Zanchetta, Jean-Pierre Devogelaer, et al.
Journal of Evaluation in Clinical Practice|September 15, 2011
Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health planYihua Xu, Hema N Viswanathan, Melea A Ward, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority studyKenneth G Saag, Rachel B Wagman, Piet Geusens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 14, 2012
Recent trends in hip fracture rates by race/ethnicity among older US adultsNicole C Wright, Kenneth G Saag, Jeffrey R Curtis, et al.
Clinical Trials (London, England)|December 19, 2013
Use of health plan combined with registry data to predict clinical trial recruitmentJeffrey R Curtis, Nicole C Wright, Fenglong Xie, et al.
Journal of the American Academy of Dermatology|June 20, 2020
Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosisKenneth G Saag, Tobias J de Villiers, Peter Alexandersen, et al.
Medical Care|March 14, 2017
Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled TrialPeter Cram, Kenneth G Saag, Yiyue Lou, et al.
Archives of Osteoporosis|January 8, 2018
Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) studyDouglas W Roblin, Peter Cram, Yiyue Lou, et al.
The Journal of Rheumatology|January 14, 2004
Nonsteroidal antiinflammatory drug toxicity monitoring and safety practicesFausto G Patino, Jason Olivieri, Jeroan J Allison, et al.
Pageof 38